
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CYBN | CBOE Canada | CAD | Real-time | |
CYBN | NYSE | USD | Real-time | |
R7E | TradeGate | EUR | Delayed |
Cybin Inc., a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. The company’s development pipeline includes CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD), as well as in preclinical trials for alcohol use disorder; CYB004, a deuterated dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders; SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 completed phase 1, 1b, and 1/2a for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat neuroinflammation, as well as has a research pipeline of investigational psychedelic-based compounds. The company has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Anthony Back | - | 2021 | Member of Clinical Advisory Board |
Thomas P. Laughren | - | 2021 | Member of Clinical Advisory Board |
Lynn Marie Morski | - | 2021 | Member of Clinical Advisory Board |
Maurizio Fava | - | 2021 | Member of Clinical Advisory Board |
Paul Glavine | 33 | 2020 | Co-Founder, Chief Growth Officer & Director |
Eric So | 46 | 2020 | Co-Founder, President & Executive Chairman |
Eric William Hoskins | 62 | 2020 | Independent Director |
Grant B. Froese | 61 | 2020 | Independent Director |
Theresa S. Firestone | 68 | 2021 | Lead Independent Director |
Mark A. Lawson | 51 | 2020 | Independent Director |
George Tziras | 43 | 2023 | Chief Business Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review